FDA Risk Management Emphasis Puts “Book Of Hazards” Back On The Table
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to convene a group of representatives from industry, academia and the agency to discuss creation of a database detailing device-specific hazards